Pathogenic LRRK2 variants are gain-of-function mutations that enhance LRRK2-mediated repression of beta-catenin signaling

Berwick, D C; Javaheri, B; Wetzel, A; Hopkinson, M; Nixon-Abell, J; Granno, S; Pitsillides, A A; Harvey, K

doi:10.1186/s13024-017-0153-4

Pathogenic LRRK2 variants are gain-of-function mutations that enhance LRRK2-mediated repression of beta-catenin signaling

Berwick, D C; Javaheri, B; Wetzel, A; Hopkinson, M; Nixon-Abell, J; Granno, S; Pitsillides, A A; Harvey, K

Authors

D C Berwick

B Javaheri

A Wetzel

M Hopkinson

J Nixon-Abell

S Granno

A A Pitsillides

K Harvey

Citation

Berwick, D. C., Javaheri, B., Wetzel, A., Hopkinson, M., Nixon-Abell, J., Granno, S., Pitsillides, A. A., & Harvey, K. (2017). Pathogenic LRRK2 variants are gain-of-function mutations that enhance LRRK2-mediated repression of beta-catenin signaling. Molecular Neurodegeneration, 12(9), https://doi.org/10.1186/s13024-017-0153-4

Journal Article Type	Article
Acceptance Date	Jan 6, 2017
Publication Date	Jan 19, 2017
Deposit Date	Apr 8, 2017
Publicly Available Date	Apr 8, 2017
Journal	Molecular Neurodegeneration
Electronic ISSN	1750-1326
Publisher	BioMed Central
Peer Reviewed	Peer Reviewed
Volume	12
Issue	9
DOI	https://doi.org/10.1186/s13024-017-0153-4
Public URL	https://rvc-repository.worktribe.com/output/1393772